In silico and preclinical drug screening identifies dasatinib as a targeted therapy for T-ALL

por Laukkanen, S, Grönroos, T, Pölönen, P, Kuusanmäki, H, Mehtonen, J, Cloos, J, Ossenkoppele, G, Gjertsen, B, Øystein, B, Heckman, C, Heinäniemi, M, Kontro, M, Lohi, O
Publicado 2017

Retinoid metabolism and all-trans retinoic acid-induced growth inhibition in head and neck squamous cell carcinoma cell lines.

por Braakhuis, B. J., Klaassen, I., van der Leede, B. M., Cloos, J., Brakenhoff, R. H., Copper, M. P., Teerlink, T., Hendriks, H. F., van der Saag, P. T., Snow, G. B.
Publicado 1997

Hypermethylation of the FANCC and FANCL Promoter Regions in Sporadic Acute Leukaemia

por Hess, C. J., Ameziane, N., Schuurhuis, G. J., Errami, A., Denkers, F., Kaspers, G. J. L., Cloos, J., Joenje, H., Reinhardt, D., Ossenkoppele, G. J., Zwaan, C. M., Waisfisz, Q.
Publicado 2008

The human equilibrative nucleoside transporter 1 mediates in vitro cytarabine sensitivity in childhood acute myeloid leukaemia

por Hubeek, I, Stam, R W, Peters, G J, Broekhuizen, R, Meijerink, J P P, Wering, E R van, Gibson, B E S, Creutzig, U, Zwaan, C M, Cloos, J, Kuik, D J, Pieters, R, Kaspers, G J L
Publicado 2005